Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Project Grant - PA: Epigenetics/epigenomics in human health or disease

University of Ottawa

$100,000.00

Exploring nuclear receptor signalling for the treatment of muscle-related diseases

FY 2019-20

Summary
Many diseases and conditions including cancer, aging and nerve injury are associated with muscle degeneration or wasting, which not only results in poor quality of life but can also be extreme debilitating and affects both patients and care givers. However, there are still no proven drugs for the prevention and treatment of these pathological conditions. We recently found that a clinically approved drug can promote the development of muscle cells. As such, we plan to continue to explore the potential of using this drug to treat muscle-related diseases. We will study the molecular pathways by which this drug promotes muscle regeneration. We will also analyze the capacity of this drug to oppose muscle wasting in relevant in vivo models. Our study is founded upon our recent findings, anchored on the ability of this drug to promote muscle development, aimed at the mechanism of muscle regeneration, and purposed to improve the quality of life and survival rate of patients. We will determine the potential of expanding the use of this drug in the clinic and provide mechanistic insight for devising novel approaches to prevent and treat muscle-related diseases. Ultimately, our project will enable the rational development of a clinically translatable method designed to increase the quality of life and the survival rate of patients suffering from muscle degeneration or wasting.
Program
Project Grant - PA: Epigenetics/epigenomics in human health or disease
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
432210
Name
Li Qiao
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Cancer Research
Theme2
Biomedical
Prcname2
Cell Biology - Disease
Projecttitle
Exploring nuclear receptor signalling for the treatment of muscle-related diseases
Programtype2
Operating Grants
Orgnameinp2
University of Ottawa
Cihramount2
$100,000
Cihrequipment2
$0
Programname2
Project Grant - PA: Epigenetics/epigenomics in human health or disease
Keyworddelim
Gene Regulation; Muscle Regeneration; Stem Cell Differentiation; Therapeutics
Abstract
Many diseases and conditions including cancer, aging and nerve injury are associated with muscle degeneration or wasting, which not only results in poor quality of life but can also be extreme debilitating and affects both patients and care givers. However, there are still no proven drugs for the prevention and treatment of these pathological conditions. We recently found that a clinically approved drug can promote the development of muscle cells. As such, we plan to continue to explore the potential of using this drug to treat muscle-related diseases. We will study the molecular pathways by which this drug promotes muscle regeneration. We will also analyze the capacity of this drug to oppose muscle wasting in relevant in vivo models. Our study is founded upon our recent findings, anchored on the ability of this drug to promote muscle development, aimed at the mechanism of muscle regeneration, and purposed to improve the quality of life and survival rate of patients. We will determine the potential of expanding the use of this drug in the clinic and provide mechanistic insight for devising novel approaches to prevent and treat muscle-related diseases. Ultimately, our project will enable the rational development of a clinically translatable method designed to increase the quality of life and the survival rate of patients suffering from muscle degeneration or wasting.
Competitiondate
202003
Approvedterm2
1 yr 0 mth
Pinamesdelim
Li, Qiao
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $100,000~ $0~
University of Ottawa - $100,000 Grant (2019-20) | Canada Spends